|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-02
|
$520,769
|
$520,769
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-02
|
$164,971
|
$164,971
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-03
|
$502,032
|
$502,032
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-04
|
$307,951
|
$307,951
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Anthraycline-related cardiotoxicity in long-term survivors of lymphoma
|
5R21CA178344-02
|
$155,521
|
$77,761
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
1R01CA181045-01A1
|
$739,531
|
$739,531
|
DIAMOND, DON
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-09
|
$2,162,001
|
$540,500
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$8,532
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$4,486
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$8,837
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$882
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$148,334
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
1U01CA183012-01
|
$465,641
|
$465,641
|
ZAIA, JOHN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-15
|
$1,885,301
|
$245,089
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S1
|
$118,825
|
$2,377
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S2
|
$75,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S3
|
$12,500
|
$250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-49
|
$10,827,666
|
$216,553
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma
|
5P01CA155258-04
|
$1,932,302
|
$173,907
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-02
|
$485,000
|
$485,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
|
5R01CA183559-02
|
$924,000
|
$924,000
|
SOIFFER, ROBERT
|
DANA-FARBER CANCER INST
|
|
Ex vivo purging strategy for treatment of multiple myeloma
|
1R41CA179706-01A1
|
$160,632
|
$160,632
|
MCFADDEN, GRANT
|
DNATRIX, INC.
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
1K08CA184552-01
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-40S1
|
$74,978
|
$2,249
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-40
|
$5,552,106
|
$166,563
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
5R01CA102707-10
|
$255,163
|
$84,204
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Home-Based Tablet Computer Pain Coping Skills Following Stem Cell Transplant
|
5R21CA173307-02
|
$165,616
|
$165,616
|
SOMERS, TAMARA
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
2R01CA136934-06
|
$353,250
|
$353,250
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$1,497
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$31,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
1R01CA188523-01A1
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$708,131
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$5,250
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$8,587
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-39
|
$4,098,686
|
$2,131,317
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-36
|
$246,190
|
$98,476
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-04
|
$170,100
|
$170,100
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-02
|
$171,372
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-04
|
$151,059
|
$151,059
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv
|
5R03CA167451-02
|
$85,360
|
$85,360
|
CHOW, ERIC
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Radioimmunotherapy for Multiple Myeloma
|
5K08CA151682-05
|
$169,560
|
$42,390
|
GREEN, DAMIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-12
|
$324,901
|
$324,901
|
PETERSDORF, EFFIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
3R01CA138720-05S1
|
$64,750
|
$64,750
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-26
|
$2,148,164
|
$257,780
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
5R01CA138720-05
|
$343,617
|
$343,617
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
|
5R01CA175008-02
|
$354,244
|
$354,244
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
2R01CA136551-06A1
|
$579,424
|
$289,712
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
2P01CA078902-16
|
$1,846,366
|
$1,846,366
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Quiescent Tc17 programmed CD8 T cells and their role in graft versus host disease
|
5R00CA154608-04
|
$241,530
|
$241,530
|
TURTLE, CAMERON
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-10
|
$376,976
|
$376,976
|
KORNGOLD, ROBERT
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
Total relevant funding to Bone Marrow Transplantation for this search: $43,140,470
|